CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes

被引:0
|
作者
Xiao-ping ZHAO Jiao ZHONG Xiao-quan LIU~2 Guang-ji WANG Key Laboratory of Drug Metabolism and Pharmacokinetics
机构
关键词
vinflunine; metabolism; CYP3A4; liver microsomes;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Aim:To study the metabolism of vinflunine and the effects of selective cyto-chrome P-450(CYP450)inhibitors on the metabolism of vinflunine in human livermicrosomes.Methods:Individual selective CYP450 inhibitors were used to inves-tigate their effects on the metabolism of vinflunine and the principal CYP450 isoforminvolved in the formation of metabolites M1and M2in human liver microsomes.Results:Vinflunine was rapidly metabolized to 2 metabolites:M1and M2in humanliver microsomes.M1and M2were tentatively presumed to be the N-oxide metabo-lite or hydroxylated metabolite and epoxide metabolite of vinflunine,respectively.Ketoconazole uncompetitively inhibited the formation of M1,and competitivelyinhibited the formation of M2,while α-naphthoflavone,sulfaphenazole,diethyldithiocarbamate,tranylcypromine and quinidine bad little or no inhibitory effecton the formation of M1and M2.Conclusion:Vinflunine is rapidly metabolized inhuman liver microsomes,and CYP3A4 is the major human CYP450 involved in themetabolism of vinflunine.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 50 条
  • [31] Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Kiyohi Natsui
    Yoshiko Mizuno
    Naoko Tani
    Masashi Yabuki
    Setsuko Komuro
    European Journal of Drug Metabolism and Pharmacokinetics, 2007, 32 : 233 - 240
  • [32] CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver
    Iwahori, T
    Matsuura, T
    Maehashi, H
    Sugo, K
    Saito, M
    Hosokawa, M
    Chiba, K
    Masaki, T
    Aizaki, H
    Ohkawa, M
    Suzuki, T
    HEPATOLOGY, 2003, 37 (03) : 665 - 673
  • [33] Involvement of CYP3A4 in the metabolism of bromperidol in vitro
    Sato, S
    Someya, T
    Shioiri, T
    Koitabashi, T
    Inoue, Y
    PHARMACOLOGY & TOXICOLOGY, 2000, 86 (03): : 145 - 148
  • [34] The CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes
    Okubo, Maho
    Murayama, Norie
    Shimizu, Makiko
    Shimada, Tsutomu
    Guengerich, F. Peter
    Yamazaki, Hiroshi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2013, 38 (03): : 349 - 354
  • [35] Comparison of the substrate kinetics of pig CYP3A29 with pig liver microsomes and human CYP3A4
    Yao, Min
    Dai, Menghong
    Liu, Zhaoying
    Huang, Lingli
    Chen, Dongmei
    Wang, Yulien
    Peng, Dapeng
    Wang, Xu
    Liu, Zhenli
    Yuan, Zonghui
    BIOSCIENCE REPORTS, 2011, 31 (03) : 211 - 220
  • [36] 6α-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes
    Araya, Z
    Wikvall, K
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1438 (01): : 47 - 54
  • [37] Cytochrome P4502C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
    Kim, KA
    Park, JY
    Lee, JS
    Lim, S
    ARCHIVES OF PHARMACAL RESEARCH, 2003, 26 (08) : 631 - 637
  • [38] CYP3A4*1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients
    Yuan, Jing-Jing
    Hou, Jun-Kai
    Zhang, Wei
    Chang, Yan-Zi
    Li, Zhi-Song
    Wang, Zong-Yu
    Du, Ying-Ying
    Ma, Xiao-Jing
    Zhang, Li-Rong
    Kan, Quan-Cheng
    Candiotti, Keith A.
    PHARMACOLOGY, 2015, 96 (1-2) : 55 - 60
  • [39] Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity
    Shen, Qi
    Zuo, Minjuan
    Ma, Li
    Tian, Ye
    Wang, Lu
    Jiang, Huidi
    Zhou, Quan
    Zhou, Hui
    Yu, Lushan
    Zeng, Su
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 224 : 89 - 99
  • [40] Effects of ginseng and ginkgo biloba components on CYP3A4 mediated testosterone 6β-hydroxylation in human liver microsomes.
    He, N
    Edeki, TI
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P50 - P50